Completed NA INTERVENTIONAL NCT00186264

Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?

Sponsor: Stanford University

Interventions hydrocortisone venlafaxine XR

Updated 6 times since 2017 Last updated: Oct 2, 2019 Started: Aug 31, 2002 Primary completion: Apr 30, 2006 Completion: Apr 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Depressive Disorder, Major and is currently completed. Stanford University leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2019 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed
Jun 2018 — Nov 2019 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University
Wyeth is now a wholly owned subsidiary of Pfizer

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States